Bank Julius Baer & Co. Ltd, Zurich
BankPosition in ARCT — Arcturus Therapeutics Holdings Inc.
CIK 1544599
ZURICH, V8
Position in ARCT
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$5,376
-$800 QoQ
Shares Held
800
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#110
of 133 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank Julius Baer & Co. Ltd, Zurich holds $177,704,514 across 10 Biotechnology names. ARCT ranks #10 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
319,371 | $158,641,156 | |
| 2 | MRNA |
Moderna, Inc.
|
93,920 | $6,577,217 | |
| 3 | BNTX |
BioNTech SE
|
61,701 | $5,741,278 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
16,575 | $4,989,572 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
13,178 | $718,728 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
12,000 | $468,120 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
718 | $447,701 | |
| 8 | BEAM |
Beam Therapeutics Inc.
|
1,710 | $58,687 |
All Filings in ARCT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,376 | 800 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $6,176 | 800 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $4,904 | 800 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $14,744 | 800 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $29,923 | 2,300 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $24,357 | 2,300 | Shares | Sole | 2025-09-17 | |
| 2024-12-31 | $35,365 | 2,084 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $586,864 | 25,285 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $663,683 | 27,256 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,477,842 | 43,762 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,489,224 | 47,232 | Shares | Sole | 2024-05-16 | |
| 2023-09-30 | $1,488,543 | 58,260 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,715,895 | 59,829 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $1,679,577 | 70,070 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,124,855 | 66,324 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $883,523 | 59,617 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,964,950 | 124,838 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $5,857,410 | 217,263 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $9,850,951 | 266,170 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $32,502,297 | 680,249 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $23,782,007 | 702,778 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $17,161,843 | 415,541 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $14,579,020 | 336,077 | Shares | Sole | 2021-02-24 | |
| 2020-09-30 | $5,802,997 | 135,268 | Shares | Sole | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||